Search results

20 items matching your search terms.
Filter the results.
Item type













New items since



Sort by relevance · date (newest first) · alphabetically
Grant to fund use of kinase test in HER2-positive breast cancer
Chapel Hill, NC – Susan G. Komen for the Cure® has awarded a grant of almost $900,000 to Lisa A. Carey, MD, and Gary Johnson, PhD, to research clinical applications for the first broad-based test for protein kinase activation and response to inhibitory drugs in HER2-positive breast cancer.
Located in News / 2012 News
UNC Lineberger scientists lead cancer genome analysis of breast cancer
Team identifies genetic causes and similarity to ovarian cancer
Located in News / 2012 News
UNC scientists publish results from breast cancer survivors wellness workshops
Scientists from UNC Lineberger have published a report describing an outreach program they developed for breast cancer survivors in four NC counties.
Located in News / 2012 News
Exercise, even mild physical activity, may reduce breast cancer risk
A new analysis done by University of North Carolina at Chapel Hill researchers has found that physical activity - either mild or intense and before or after menopause - may reduce breast cancer risk, but substantial weight gain may negate these benefits.
Located in News / 2012 News
Parise and Leisner research into protein CIB1 profiled in Raleigh News and Observer
The Raleigh News and Observer interviewed Leslie Parise, PhD, professor and chair of the department of biochemistry, and Tina Leisner, PhD, a UNC research associate in biochemistry, about their research into the linkage between breast cancer and the protein CIB1.
Located in News / 2012 News
Amos quoted in ABC News feature
Keith Amos, MD, assistant professor of surgery at UNC-Chapel Hill, is quoted in an ABC News feature discussing a new study about partial breast removal surgery to treat cancer.
Located in News / 2012 News
UNC study: New genomic test may guide breast cancer treatment choices
UNC study: New genomic test may guide breast cancer treatment choices
Located in News / 2011 News
Editorial urges rapid clinical trials for targeted breast cancer therapies
Chapel Hill, NC – In an editorial published today in the Journal of Clinical Oncology, UNC associate professor E. Claire Dees, MD, reviews current evidence on the safety and efficacy of combination therapies currently used for metastatic breast cancer and urges clinical researchers to move forward with new studies that leverage advances in the identification of tumor biomarkers.
Located in News / 2011 News
UNC radiation oncologists co-author Journal of Clinical Oncology editorial on breast cancer radiotherapy and coronary artery stenosis
Timothy Zagar, MD, assistant professor of radiation oncology, and Lawrence Marks, MD, professor and chair of radiation oncology, co-authored an editorial in the December 27, 2011 issue of the Journal of Clinical Oncology.
Located in News / 2012 News
Common transplant drug inhibits breast cancer growth, UNC laboratory study shows
Chapel Hill - Tacrolimus, a drug that is commonly used to prevent organ transplantation rejection, inhibits breast cancer growth in pre-clinical studies. The finding from UNC scientists was reported in the May 26th Public Library of Science.
Located in News / 2011 News